self-amplifying RNA vaccine (GlaxoSmithKline)

N/A

Report date: 2025/03/20 09:27:22

Base Information

Drug Nameself-amplifying RNA vaccine (GlaxoSmithKline)
Drug Alias Nameself-amplifying RNA vaccine (Novartis Vaccines and Diagnostics)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Vaccines And Diagnostics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Vaccines And Diagnostics IncGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A